The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis.

Cheng, Huawei; Shang, Yuping; Jiang, Ling; Shi, Tian-lu; Wang, Lin

Cheng, Huawei; Shang, Yuping; Jiang, Ling; Shi, Tian-lu; Wang, Lin.

Affiliation

Cheng H; a Department of Pharmacy, Anhui Cancer Hospital , Hefei , China.
Shang Y; a Department of Pharmacy, Anhui Cancer Hospital , Hefei , China.
Jiang L; b Department of Pharmacy, Anhui Provincial Hospital , Hefei , China.
Shi TL; b Department of Pharmacy, Anhui Provincial Hospital , Hefei , China.
Wang L; c Clinical Laboratory, the First Affiliated Hospital of Anhui University of Chinese Medicine , Hefei , China.

Int J Neurosci ; 126(4): 299-307, 2016.

Article in En | MEDLINE | ID: mdl-26001206

Subject(s)

Alzheimer Disease/drug therapy; Alzheimer Disease/metabolism; Benzimidazoles/therapeutic use; Benzoates/therapeutic use; PPAR gamma/agonists; Thiazolidinediones/therapeutic use; Humans; Pioglitazone; Rosiglitazone; Telmisartan

Key words

Alzheimer's disease; PPAR-Î³ agonists; meta-analysis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzimidazoles / Benzoates / Thiazolidinediones / PPAR gamma / Alzheimer Disease Type of study: Clinical_trials / Etiology_studies / Systematic_reviews Limits: Humans Language: En Journal: Int J Neurosci Year: 2016 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google